期刊文献+

回访服务对提高心肌梗死PCI术后患者生活质量的调查研究

Return service to improve myocardial infarction patients after PCI investigation of quality of life
下载PDF
导出
摘要 目的探讨分析回访服务对心肌梗死PCI术后患者生活质量的影响。方法随机选取2008年5月至2010年6月在我院住院的心肌梗死PCI术后患者126例,并将他们随机平均分成实验组和对照组,在所有患者出院后,对实验组患者进行回访服务,对照组不进行回访及系统的教育,对比分析两组患者的血脂、血压、药物依从性和生活质量等指标。结果在患者术后一年后,给予回访服务的实验组患者实验组患者的血压、血脂达标的患者分别有49和51例,达标率分别为77.78%、80.95%,而对照组患者血压、血脂达标的患者仅有25和17例,达标率分别为38.68%和26.98%,明显低于实验组,差异有统计学意义(P<0.05);另外,实验组患者的药物依从性和生活质量也明显高于对照组患者,差异有统计学意义(P<0.05)。结论回访服务能够提高心肌梗死PCI术后患者的临床治疗效果和他们的生活质量,值得在临床上推广应用。 Objective To investigate the analysis of return visit service on myocardial infarction in PCI patients quality of life. Methods From May to 2010 June 2008 randomly selected in our hospital in myocardial infarction patients after PCI in 126 cases, And were randomly divided into experimental group and control group, In all patients after discharge from hospital, The experimental group patients pay a return visit service, The control group were not to return and systematic education, Comparative analysis of two groups of patients with serum lipids, blood pressure, drug compliance and quality of life indicators. Results In postoperative patients after one year, Give a return visit service the patients in the experimental group in the experimental group, blood pressure, blood lipids of patients with respectively 49 and 51 cases, Compliance rates were 77.78%, 80.95%, while the control group patients' blood pressure, blood lipids of patients with only 25 and 17 cases, Compliance rates were 38.68% and 26.98%, Was significantly lower in the experimental group, The difference was statistically significant (P〈0.05); In addition, the experimental group patients medication compliance and quality of life were significantly higher than those in control group patients, The difference was statistically significant (P〈0.05). Conclusion Teturn visit service can improve myocardial infarction patients after PCI of clinical therapeutic effects and their quality of life, Worthy of clinical application.
机构地区 茂名市人民医院
出处 《心血管病防治知识(学术版)》 2012年第1期20-21,共2页 Prevention and Treatment of Cardiovascular Disease
关键词 回访服务 心肌梗死PCI术 生活质量 临床效果 Return service Myocardial infarction with PCI technique Quality of life Clinical effect
  • 相关文献

参考文献4

二级参考文献14

  • 1谭慧琼,朱俊,梁岩,章晏,刘力生,代表OASIS登记试验中国地区协作组.非ST段抬高的急性冠状动脉综合征二年随访[J].中华医学杂志,2005,85(3):184-188. 被引量:12
  • 2Piegas LS, Flather M, Pogue J,et al. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) registry in patients with unstable angina. Am J Cardiol,1999,84: 7M-12M.
  • 3Newby LK, Bhapkar MV, White HD,et al. Predictors of 90-day outcome in patients stabilized after acute coronary syndromes. Eur Heart J, 2003,24:172-181.
  • 4Theroux P, Fuster V. Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. Circulation,1998,97: 1195-1206.
  • 5Cohen M, Demers C, Gurfinkel EP,et al. A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease: Efficacy and Safety of Subcutaneous Enoxparin in Non-Q-wave Coronary Events Study Group. N Engl J Med,1997,337: 447-452.
  • 6Spencer FA, Santopinto JJ, Gore JM, et al. Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol,2002,90:1056-1061.
  • 7Chang WC, Harrington RA, Simoons ML, et al. Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT Trial. Eur Heart J,2002 ,23:1102-1111.
  • 8Gurfinkel EP, J Manos EJ, Mejail RI, et al. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. J Am Coll Cardiol,1995,26: 313-318.
  • 9The SYNERGY Executive Committee. Superior Yield of the New strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa inhibitors. The SYNERGY trial: study design and rationale. Am Heart J,2002,143:952-960.
  • 10The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med,2000,342: 145-153.

共引文献4994

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部